Absence of Kaposi\u27s Sarcoma-Associated Herpesvirus DNA in Bacillary
Angiomatosis-Peliosis Lesions by Relman, David A. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
U.S. Department of Veterans Affairs Staff 
Publications U.S. Department of Veterans Affairs 
1999 
Absence of Kaposi's Sarcoma-Associated Herpesvirus DNA in 
Bacillary Angiomatosis-Peliosis Lesions 
David A. Relman 
Stanford University School of Medicine, relman@stanford.edu 
David N. Fredricks 
Stanford University School of Medicine, fredrick@cmgm.stanford.edu 
Kristine E. Yoder 
Stanford University 
Ginat Mirowski 
Stanford University 
Timothy Berger 
Stanford University 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/veterans 
Relman, David A.; Fredricks, David N.; Yoder, Kristine E.; Mirowski, Ginat; Berger, Timothy; and Koehler, 
Jane E., "Absence of Kaposi's Sarcoma-Associated Herpesvirus DNA in Bacillary Angiomatosis-Peliosis 
Lesions" (1999). U.S. Department of Veterans Affairs Staff Publications. 12. 
https://digitalcommons.unl.edu/veterans/12 
This Article is brought to you for free and open access by the U.S. Department of Veterans Affairs at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in U.S. Department of Veterans 
Affairs Staff Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
David A. Relman, David N. Fredricks, Kristine E. Yoder, Ginat Mirowski, Timothy Berger, and Jane E. 
Koehler 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
veterans/12 
1386 
CONCISE COMMUNICATIONS 
Absence of Kaposi's Sarcoma-Associated Herpesvirus DNA in Bacillary 
Angiomatosis-Peliosis Lesions 
David A. Relman,1-3 David N. Fredricks,12 
Kristine E. Yoder,1Aa Ginat Mirowski,4-3 
Timothy Berger,4 and Jane E. Koehler5 
1Department of Veterans Affairs Palo Alto Health Care System, 
Palo Alto, and Departments of2Medicine and 3Microbiology 
and Immunology, Stanford University, Stanford, California; 
Departments of *Dermatology and 5Medicine, University 
of California, San Francisco 
Bartonella henselae and B. quintana induce an unusual vascular proliferative tissue response 
known as bacillary angiomatosis (BA) and bacillary peliosis (BP) in some human hosts. The 
mechanisms of itorto/ie/fa-associated vascular proliferation remain unclear. Although host 
factors probably play a role, microbial coinfection has not been ruled out. Because of the 
vascular proliferative characteristics noted in both Kaposi's sarcoma (KS) and BA and oc- 
casional colocalization of KS and BA, the possibility was explored that KS-associated her- 
pesvirus (KSHV) might be associated with BA lesions. Tissues with BA and positive and 
negative control tissues were tested for the presence of KSHV DNA by a sensitive polymerase 
chain reaction assay. Only 1 of 10 BA tissues, a splenic biopsy, was positive in this assay; this 
tissue was from a patient with concomitant KS of the skin. Thus, KSHV is probably not 
involved in the vascular proliferative response seen in BA-BP. 
Vascular proliferation is characteristic of the local tissue re- 
sponse to several microbial pathogens, including Bartonella ba- 
cilliformis, B. henselae, and B. quintana. When immunocom- 
promised persons are infected with the latter two species, 
bacillary angiomatosis (BA) and bacillary peliosis (BP) may 
develop [1, 2]. In contrast, immunocompetent persons rarely 
develop BA-BP [3]; they more typically develop granulomatous 
(cat-scratch disease) and bacteremic disease (trench fever) with- 
out angioproliferation during infection with B. henselae and B. 
quintana, respectively [4]. 
At least four hypotheses explain the variable host response 
to B. henselae and B. quintana. First, the state of immune com- 
petence determines whether host angioproliferative factors are 
expressed locally; second, only certain Bartonella strains with 
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angiogenic potential circulate among immunocompromised 
persons; third, greater degrees of local Bartonella replication 
occur in the face of host immunosuppression, resulting in 
greater bacterial production of vascular proliferative factors; 
and fourth, BA and BP occur only in the presence of a coinfect- 
ing agent with angiogenic properties [5]. 
The ability of one pathogen to modify the host response to 
a coinfecting organism is an increasingly common theme [6]. 
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is the 
putative cause of KS, a disease characterized by vascular pro- 
liferation [7]. Many of the persons at greatest risk for BA and 
BP are also infected with KSHV The local host cellular re- 
sponses to KSHV might create a permissive or favorable en- 
vironment for the formation of BA. The striking colocalization 
of macroscopic KS and BA cutaneous lesions in several patients 
(see case report below) also stimulated our interest in investi- 
gating this hypothesis. The question was whether KSHV could 
be detected at the molecular level in lesions that appeared to 
be BA without KS at the macroscopic level. Therefore, we 
investigated the possible coassociation of Bartonella and KSHV 
within the vascular proliferative lesions of BA, using assays 
based upon the polymerase chain reaction (PCR). 
Materials and Methods 
Patients and tissue specimens. We studied 10 tissue specimens 
with pathology typical of either BA or BP (BA1-BA10) and 3 tissue 
specimens with pathology typical of KS (KS1-KS3) from 13 un- 
related patients, along with control samples (C1-C8), in a blinded 
fashion. Nine of the 10 BA-BP (herein referred to as "BA") spec- 
imens were skin lesions; all but 1 of these 9 patients were human 
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Figure 1. A, Close-up view of representative cutaneous lesions reveals well-demarcated violaceous plaques. Within plaques are irregularly 
arranged smooth, rounded red papules suggestive of bacillary angiomatosis/bacillary peliosis (BA). B, High-power view of superficial dermis from 
cutaneous biopsy specimen (hematoxylin-eosin stain) reveals lobulated vessels lined by plump, cuboidal endothelial cells, consistent with BA. 
Associated with superficial structures are amorphous clumps of lightly basophilic material. Warthin-Starry silver stain (insert) reveals aggregates 
of bacillary organisms (arrows). C, High-power view of deep reticular dermis from cutaneous biopsy specimen shows spindled cells forming 
irregular, slit-like vessels with extravasated red blood cells and hemosiderin, consistent with Kaposi's sarcoma. 
immunodeficiency virus (HIV) seropositive. The HIV-seronegative 
patient with cutaneous BA was apparently immunocompetent and 
has been reported [3]. The tenth specimen (BA4) was spleen tissue 
with BP from an HIV-seropositive person. All 3 KS specimens were 
skin biopsies from HIV-seropositive patients. Eight coded "nega- 
tive-control" samples were collected at the same institution as the 
BA and KS specimens and included 1 skin sample from an HIV- 
seronegative person (Cl), 1 spleen sample from an HIV-seropositive 
person (C2), 2 spleen samples from HIV-seronegative persons (C3, 
C5), liver (C4) and bone (C6) from HIV-seropositive persons, a 
water sample (C7), and tissue digestion buffer (C8). All of the 
tissues listed were digested using a procedure described elsewhere 
[1] and then sent to one of the coauthors at a different institution 
for further analysis. 
PCR assays. A PCR assay for 16S rDNA from Bartonella 
species and closely related a-proteobacteria was performed with 
primers 12E and 24B as described elsewhere [8]. All digested tissues 
were tested for human 0-globin gene sequences with primers GH20 
and PC04 using established conditions [8]. KSHV open-reading 
frame (ORF) 26 (minor capsid gene) DNA (KS330233) was detected 
using two primers described by Chang et al. [7], KS-223F (5'- 
AGCCGAAAGGATTCCACCAT-3') and KS-223R (5'-TCCGT- 
GTTGTCTACGTCCAG-3'). The KSHV ORF 26 assay was done 
with the conditions described originally [7] as well as with the 
following modified conditions: 2 mM MgCl2, 200 C1M of each 
dNTP, 800 nM of each primer, 1 U of Amplitaq gold (Perkin- 
Elmer, Norwalk, CT), a 50-CIL final reaction volume, 94vC incu- 
bation for 10 min, followed by 50 cycles comprising 94iC for 30 
s, 580C for 30 s, 720C for 30 s, and then a 7-min incubation at 
72wC. The sensitivity of the KSHV assay was determined using the 
modified set of conditions and serial dilutions of a plasmid con- 
taining a 600-bp fragment of ORF 26, which includes the two 
primer annealing sites (gift of D. Kedes and D. Ganem, University 
of California, San Francisco). In addition to controls C1-C8, neg- 
ative controls included reactions with water and PCR reagents. All 
reactions were set up and analyzed in two different rooms; since 
BA, KS, and control specimens were analyzed in a blinded, coded 
fashion, positive and negative samples were randomly interspersed 
during analysis. 
Case Report 
A 37-year-old homosexual man with AIDS and 104 CD4 
cells/mm3 was diagnosed with KS 2 years before admission. He 
was undergoing treatment for cytomegalovirus (CMV) esoph- 
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Figure 2. Agarose gel electrophoresis of DNA products from Ka- 
posi's sarcoma-associated herpesvirus (KSHV) open-reading frame 26 
polymerase chain reaction assay (using modified experimental proto- 
col). By lane: 1, tissue BAl; 2, BA2; 3, BA3; 4, KS1; 5, KS2; 6, Cl; 
7, BA4, 8, water; 9, digestion buffer; 10, water; 11, 105 target copies; 
12, 102 target copies; 13, 5 target copies; 14, 1 target copy. At right of 
each panel is 100-bp DNA ladder (200- and 300-bp bands indicated). 
Expected size of product from KSHV genome is 233 bp. BA, bacillary 
angiomatosis. 
agitis and retinitis and diffuse cutaneous KS and was trans- 
fusion dependent. Three weeks before admission, he completed 
two cycles of bleomycin and vincristine. Subsequently, he de- 
veloped daily fevers to 380C and epigastric and right upper 
quadrant abdominal pain and was admitted for evaluation of 
CMV cholangitis. On admission, his temperature was 390C. 
Physical examination revealed an enlarged liver and palpable 
spleen tip. Cutaneous findings included extensive, well-demar- 
cated, violaceous cutaneous plaques. Localized and limited to 
and within these plaques were irregularly arranged smooth, 
rounded red papules and nodules, whose appearance was sus- 
picious for BA (figure lA). Skin biopsy specimens were ob- 
tained for histopathology and culture before initiation of an- 
tibiotics. The histopathologic findings revealed both KS and 
BA. In the superficial dermis (figure IB), lobulated vascular 
structures lined by plump, cuboidal endothelial cells were 
found. Associated with the superficial vascular structures were 
amorphous clumps of lightly basophilic material, which were 
clumps of bacillary organisms on Warthin-Starry silver staining 
(figure IB insert), consistent with BA. In contrast, in the deep 
reticular dermis (figure 1 C), spindled cells formed irregular slit- 
like structures with extravasated red blood cells and hemosid- 
erin consistent with KS. 
B. henselae was isolated from the blood and from the cu- 
taneous BA-KS lesion. On further questioning, the patient re- 
called having received a serious cat scratch 3 years earlier. The 
patient was treated with erythromycin but developed pleural 
effusion, pneumothorax, and acute renal failure and died on 
hospital day 17. An autopsy revealed disseminated BA, peliosis 
hepatitis, and generalized KS. Colocalization of BA and KS 
also occurred in the gastrointestinal tract and the lung. There 
was no evidence of cholangitis. 
Results 
Confirmation of diagnosis in BA and KS tissues. All 10 BA 
tissue digests yielded products of the expected size (296 bp) with 
the Bartonella range-restricted PCR assay, while none of the 
KS digests or controls generated any visible product (data not 
shown). Bartonella species (either B. henselae or B. quintana) 
were cultivated from some, and Bartonella species 16S rDNA 
was detected by amplification and DNA sequencing in all of 
the same BA specimens in previous experiments in a different 
laboratory [2]. A DNA product of the expected size (233 bp) 
was amplified from all 3 KS specimen digests by use of the 
KSHV PCR assay with both experimental protocols (see figure 
2, lanes 4 and 5) and not from any digest buffer or PCR reagent- 
only controls (figure 2, lanes 8-10). By use of serial dilutions 
of cloned ORF 26 template DNA, the sensitivity of the KSHV 
PCR assay with the modified protocol was estimated to be 5 
template copies (see figure 2, lanes 11-14). 
All but 1 of the 19 tissue digests yielded an amplified product 
of the expected size using human 0-globin gene primers on 
repeated testing over a 2-year period (data not shown); the 
exception (Cl) was positive for 0-globin DNA at the time of 
initial Bartonella and KSHV PCR testing; however, it was neg- 
ative in the 0-globin PCR assay 2 years later, when the modified 
KSHV assay was performed. These results provide evidence 
that all of the BA and KS tissues were infected with Bartonella 
species or KSHV, respectively, as one would have predicted, 
and that the tissue digests all contained amplifiable DNA. 
Assessment of KSHV infection in BA and control tissues. 
No evidence of KSHV DNA was found in 9 of the 10 BA 
specimens. From specimen BA4, a product of the expected size 
was detected using the modified KSHV PCR assay (figure 2, 
lane 7). BA4 was a spleen sample with typical BP histology 
from an HIV-seropositive patient who had biopsy-proven cu- 
taneous KS. Four of the 6 tissue controls with normal histology 
were negative in this KSHV PCR assay (C1, C3, C5, C6); tissues 
C2 and C4 were positive despite the absence of any pathology. 
C2 was splenic tissue from an HIV-seropositive person with 
intra-abdominal lymphatic KS. This result and that from BA4 
might be explained by the known ability of KSHV to dissem- 
inate within the host well beyond sites of typical KS pathology 
[7, 9]. The other control tissue that yielded an unexpected pos- 
itive result in the KSHV assay was a liver specimen (C4) with 
no evidence of KS from an HIV-seropositive person with an- 
gioimmunoblastic lymphadenopathy (AILD). In one study, 
KSHV DNA was detected in 3 of 15 tissue specimens with this 
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lymphoproliferative disease [10]. While our findings in this case 
and this study raise interesting questions about the possible role 
of this virus in AILD, we cannot exclude a noncausal associ- 
ation in a host at elevated risk for KSHV acquisition. 
Discussion 
KSHV has been associated with body cavity-based lym- 
phoma, multicentric Castleman's disease, AILD, and KS. This 
virus encodes homologues of chemokine-like proteins vMIP-I 
and vMIP-II, which are angiogenic in vitro [11]. Our case and 
other similar cases have drawn attention over the past decade 
to the possibly frequent coassociation of KSHV and Bartonella 
species in BA lesions and a possible role for KSHV as a cofactor 
in the vascular proliferation of BA-BP. However, the results of 
our study argue against these possibilities. Our data indicate 
that if KSHV is found in BA lesions, it occurs infrequently or 
in extremely low numbers. These data suggest that KSHV is 
unlikely to be a cofactor in the vascular proliferation associated 
with BA bacilli and suggest that research efforts be focused on 
other possibilities. While the vascular proliferation in BA and 
BP may involve host induction or bacterial production of 
growth factors and cytokines that promote new vessel forma- 
tion [12], the exact mechanisms of this fascinating and unusual 
host response to infection remain to be elucidated. 
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